MedPath

Prostaglandin E2

Generic Name
Prostaglandin E2
Brand Names
Cervidil, Prepidil, Prostin E2
Drug Type
Small Molecule
Chemical Formula
C20H32O5
CAS Number
363-24-6
Unique Ingredient Identifier
K7Q1JQR04M
Background

Dinoprostone is a naturally occurring prostaglandin E2 (PGE2). It has important effects in labour. It also stimulates osteoblasts to release factors which stimualtes bone resorption by osteoclasts. As a prescription drug it is used as a vaginal suppository, to prepare the cervix for labour and to induce labour.

Indication

For the termination of pregnancy during the second trimester (from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period), as well as for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period. Also used in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole). Other indications include improving the cervical inducibility (cervical "ripening") in pregnant women at or near term with a medical or obstetrical need for labor induction, and the management of postpartum hemorrhage.

Associated Conditions
Gestational Trophoblastic Neoplasia
Associated Therapies
Induction of cervix ripening therapy, Medically induced abortion, Uterus evacuation

Dinoprostone Versus Vaginal Misoprostol for Induction of Labour

Not Applicable
Completed
Conditions
Induced Vaginal Delivery
Interventions
First Posted Date
2024-08-19
Last Posted Date
2024-08-19
Lead Sponsor
University of Alexandria
Target Recruit Count
370
Registration Number
NCT06560515
Locations
🇪🇬

ElShatby University Maternal Hospital, Alexandria, Egypt

Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction

Phase 3
Recruiting
Conditions
Fetal Growth Retardation
Interventions
Device: Cook´s balloon
First Posted Date
2023-03-17
Last Posted Date
2023-04-25
Lead Sponsor
Hospital Universitario 12 de Octubre
Target Recruit Count
172
Registration Number
NCT05774236
Locations
🇪🇸

Hospital Universitario 12 de Octubre, Madrid, Spain

🇪🇸

Hospital Clinic i Provincial, Barcelona, Spain

🇪🇸

Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain

Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy

Phase 3
Completed
Conditions
Myoma;Uterus
Interventions
First Posted Date
2023-03-09
Last Posted Date
2023-03-09
Lead Sponsor
Beni-Suef University
Target Recruit Count
90
Registration Number
NCT05761418
Locations
🇪🇬

Beni-suef university, Banī Suwayf, Egypt

Dinoprostone Induction vs. Expectant Management After PROM at Term

Phase 4
Conditions
Prelabor Rupture of Membranes
Interventions
First Posted Date
2022-06-24
Last Posted Date
2022-06-24
Lead Sponsor
University Medical Centre Ljubljana
Target Recruit Count
70
Registration Number
NCT05430711

Gemeprost Versus Dinoprostone in First Trimester Miscarriages

Phase 2
Recruiting
Conditions
Incomplete Abortion
Missed Abortion
Medical; Abortion, Fetus
Interventions
First Posted Date
2022-04-22
Last Posted Date
2024-01-23
Lead Sponsor
National University of Malaysia
Target Recruit Count
174
Registration Number
NCT05342467
Locations
🇲🇾

UKM Medical Centre, Kuala Lumpur, W.Persekutuan, Malaysia

🇲🇾

UKM Medical Center, Kuala Lumpur, W.Persekutuan, Malaysia

DOuble-BAlloon Versus PROstaglandin E2 for Cervical Ripening in Low Risk Pregnancies

Not Applicable
Recruiting
Conditions
Induction of Labor
Interventions
Device: Double-balloon catheter (UTAH CVX-RIPE) for cervical ripening
First Posted Date
2021-02-10
Last Posted Date
2024-03-01
Lead Sponsor
Hanoi Obstetrics and Gynecology Hospital
Target Recruit Count
540
Registration Number
NCT04747301
Locations
🇻🇳

Hanoi Obstetrics and Gynecology Hospital, Hanoi, Hà Nội, Vietnam

Labor Induction After Failed Induction With Dinoprostone.

Not Applicable
Completed
Conditions
Induction of Labor Affected Fetus / Newborn
Interventions
Device: Cervical ripening balloon.
First Posted Date
2020-10-22
Last Posted Date
2022-04-20
Lead Sponsor
Rambam Health Care Campus
Target Recruit Count
144
Registration Number
NCT04597333
Locations
🇮🇱

Rambam health care campus, Haifa, Israel

Vaginal Dinoprostone Versus Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy

Not Applicable
Conditions
Postmenopausal Bleeding
Interventions
First Posted Date
2020-08-05
Last Posted Date
2021-09-29
Lead Sponsor
Aswan University Hospital
Target Recruit Count
200
Registration Number
NCT04500496
Locations
🇪🇬

Aswan University Hospital, Aswan, Egypt

Comparison of Two Rhythm of Administration of Prostaglandin Gel for Induction of Labor

Phase 2
Completed
Conditions
Labor Complication
Cervix
Interventions
First Posted Date
2020-06-04
Last Posted Date
2023-07-19
Lead Sponsor
University Hospital Center of Martinique
Target Recruit Count
268
Registration Number
NCT04413890
Locations
🇲🇶

University Hospital of Martinique, Fort-de-France, Martinique

Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Abdominal Myomectomy

Phase 4
Conditions
Myomectomy
Interventions
Drug: intravenous tranexamic acid
Drug: vaginal placebo
First Posted Date
2020-04-22
Last Posted Date
2020-04-22
Lead Sponsor
Cairo University
Target Recruit Count
180
Registration Number
NCT04357002
© Copyright 2025. All Rights Reserved by MedPath